An FDA panel meets today to consider whether antidepressants should carry warnings of heightened suicide risks in adults. The agency adopted a similar requirement in 2004 aimed at children and adolescents, but a lively debate has ensued since then about the drugs' effects on adults.

Full Story:

Related Summaries